Frederik Deiman (also known as Frits Deiman) is a cardiovascular researcher focusing on genetic cardiomyopathies and precision medicine. His work integrates disease modeling, patient-derived cardiac tissue, stem cell–based models, and multi-omics approaches, to elucidate disease mechanisms, identify therapeutic targets and evaluate the potential of novel drugs, particularly gene therapy.
